RCB
DEAD

Serial Number

97205537

Owner

Delphi Diagnostics, Inc.

Attorney

Naira Simmons

Filing Date

Jan 6, 2022

Add to watchlist:

No watchlists yet
View on USPTO

RCB Trademark

Serial Number: 97205537

RCB is a trademark filed by Delphi Diagnostics, Inc. on January 6, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services). The application is currently no longer active.

Owner Contact Info

Delphi Diagnostics, Inc. (10 trademarks)

PO Box 341449
Austin, TX 78734

Entity Type: 03

Trademark Details

Filing Date

January 6, 2022

Registration Date

Not Registered

Published for Opposition

June 28, 2022

Goods & Services

Biological preparations for the treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Anti-cancer preparations; Protein arrays for diagnosing cancer; Biological preparations for the assessment of recurrence of cancer; Pharmaceutical products for the assessment of a treatment of viral and infectious diseases, for the assessment of treatment of cancer; assessment for anti-cancer preparations; assessment of protein arrays for diagnosing cancer

Providing a website via a global computer network featuring supportive personal stories on the subjects of health, cancer, cancer recovery and survival

Medical testing, prediction and assessment for diagnostic, prognosis and treatment purposes in the field of cancer research and disease classification; Providing medical, assessment and prediction information to medical professionals in the field of cancer and disease classification; Providing medical information, assessment and prediction to medical professionals on sensitivities of cancers to hormones and/or hormone therapies

Medical apparatus or device for assessing the recurrence of cancer; Medical diagnostic apparatus for assessing and predicting recurrence of cancer cells incorporating recorded operating system software; Medical nanites for assessing and predicting the recurrence of cancer; Medical nanorobots for assessing and predicting recurrence of cancer; Medical microrobots for assessing and predicting recurrence of cancer after treatment

Medical and scientific research in the field of assessing and predicting recurrence cancer after treatment and diagnosis; Medical research services in the field of assessing and predicting recurrence of cancer; Providing laboratory research services in the field of assessing and predicting effectiveness of treatment and diagnosis in gene expression, namely, cancer biology; Research and development of pharmaceuticals for the assessment and prediction of effectiveness of treatment of age-related diseases and cancer; Assessment and predictions of medical diagnosis and treatment of cancer; Providing information about medical research, predictions and assessments in the field of cancer

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Sep 25, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Sep 25, 2023 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 2, 2023 EXRA
SOU EXTENSION 1 GRANTED
Jan 31, 2023 EX1G
SOU EXTENSION 1 FILED
Jan 31, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 31, 2023 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 30, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 30, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 30, 2023 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 23, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 28, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jun 28, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 8, 2022 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 25, 2022 PREV
ASSIGNED TO LIE
May 20, 2022 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
May 18, 2022 CNSA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
May 3, 2022 ZZZX
APPROVED FOR PUB - PRINCIPAL REGISTER
May 3, 2022 CNSA
ASSIGNED TO EXAMINER
May 3, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 10, 2022 NWOS
NEW APPLICATION ENTERED
Jan 10, 2022 NWAP